US Patent Issued to Novartis on Sept. 23 for "Methods of treating chronic spontaneous urticaria using a bruton's tyrosine kinase inhibitor" (Swiss, American, German, French Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,889, issued on Sept. 23, was assigned to Novartis AG (Basel, Switzerland).

"Methods of treating chronic spontaneous urticaria using a bruton's tyrosine kinase inhibitor" was invented by Souvik Bhattacharya (Weymouth, Mass.), Bruno Bieth (Saint-Louis, France), Maciej Cabanski (Allschwil, Switzerland), Bruno Cenni (Sissach, Switzerland), Stefan De Buck (Buesserach, Switzerland), Martin Kaul (Neustadt, Germany), Arvind Kinhikar (Cambridge, Mass.), Andrijana Radivojevic (New York), Thomas Severin (Freiburg, Germany), Julian Storim (Basel, Switzerland) and Alessandra Vitaliti Garami (Oberwil, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Th...